First T-Cell Therapy to Reduce Disease after Cell Transplant

by Devices and Pharma | Jul 31, 2026 | Cell Therapy, FDA Approvals, Gene Therapy, Industry Information, Industry News, New Biologics, Products_biologics, Stem Cells, T-Cell Therapy

Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA Approves First Regulatory T-Cell...

Casgevy Gene Therapy Expanded to 2-Year-Old Children

by Devices and Pharma | Jul 16, 2026 | FDA Public Information, FDA_Innovation, Gene Therapy, Gene Therapy, Industry Information, Industry News, Products_biologics

Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA Expands Casgevy Gene Therapy...

FDA Approves First Gene Therapy for Genetic Hearing Loss

by Devices and Pharma | Apr 24, 2026 | Biologics-information, Gene Therapy, Industry Information, Industry News, Product-Innovation, Products_biologics, Products_Combination, Products_Devices

Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA Approves First Gene Therapy for...

FDA’s Orphan Drug Program

by Devices and Pharma | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, Product-Innovation, Products_biologics, Products_Devices, Products_Drugs, Reg_Products, US-FDA

FDA's Orphan Drug Program To encourage the development of drugs and biologics for rare diseases or conditions Home About Consumer Medical Devices Pharma AI Regulatory Quality QMSR Central News Enforcement Alerts Innovation Contact Expedite Development of New Orphan...